First report of robot-assisted transperineal fusion versus off-target biopsy in patients undergoing repeat prostate biopsy

[1]  P. Pepe,et al.  Transperineal Versus Transrectal MRI/TRUS Fusion Targeted Biopsy: Detection Rate of Clinically Significant Prostate Cancer , 2017, Clinical genitourinary cancer.

[2]  G. Nabi,et al.  Combined T2 and diffusion-weighted MR imaging with template prostate biopsies in men suspected with prostate cancer but negative transrectal ultrasound-guided biopsies , 2016, World Journal of Urology.

[3]  Saila Kauppila,et al.  Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial. , 2016, European urology.

[4]  Osamu Ukimura,et al.  A Randomized Controlled Trial To Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy. , 2016, European urology.

[5]  K. Nikolaou,et al.  Prostate cancer gene 3 (PCA3) is of additional predictive value in patients with PI-RADS grade III (intermediate) lesions in the MR-guided re-biopsy setting for prostate cancer , 2016, World Journal of Urology.

[6]  A. Cheng,et al.  The state of TRUS biopsy sepsis: readmissions to Victorian hospitals with TRUS biopsy‐related infection over 5 years , 2015, BJU international.

[7]  Erhard Godehardt,et al.  Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies. , 2015, European urology.

[8]  Pierre Mozer,et al.  Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic Review. , 2015, European urology.

[9]  Baris Turkbey,et al.  Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. , 2015, JAMA.

[10]  Heinz-Peter Schlemmer,et al.  Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance. , 2015, The Journal of urology.

[11]  M. Roethke,et al.  Direct Comparison of Targeted MRI-Guided Biopsy with Systematic Transrectal Ultrasound-Guided Biopsy in Patients with Previous Negative Prostate Biopsies , 2014, Urologia Internationalis.

[12]  Tobias Penzkofer,et al.  Prostate cancer detection and diagnosis: the role of MR and its comparison with other diagnostic modalities – a radiologist's perspective , 2014, NMR in biomedicine.

[13]  K. Kihara,et al.  Combination of diffusion-weighted magnetic resonance imaging and extended prostate biopsy predicts lobes without significant cancer: application in patient selection for hemiablative focal therapy. , 2014, European urology.

[14]  J. Fütterer,et al.  Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. , 2013, European urology.

[15]  F. Aragona,et al.  Morbidity after transperineal prostate biopsy in 3000 patients undergoing 12 vs 18 vs more than 24 needle cores. , 2013, Urology.

[16]  Shyam Natarajan,et al.  Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device. , 2013, The Journal of urology.

[17]  P. Johnstone,et al.  Risk of Gleason grade inaccuracies in prostate cancer patients eligible for active surveillance. , 2012, Urology.

[18]  J. Raman,et al.  Complications following prostate needle biopsy requiring hospital admission or emergency department visits – experience from 1000 consecutive cases , 2012, BJU international.

[19]  D. Schilling,et al.  MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy , 2012, World Journal of Urology.

[20]  J. Fütterer,et al.  ESUR prostate MR guidelines 2012 , 2012, European Radiology.

[21]  P Mohan,et al.  Robotic transperineal prostate biopsy: pilot clinical study. , 2011, Urology.

[22]  B. Carey,et al.  Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. , 2011, European urology.

[23]  Y. Naya,et al.  Improved prostate cancer detection using systematic 14-core biopsy for large prostate glands with normal digital rectal examination findings. , 2006, Urology.

[24]  M Bolla,et al.  EAU guidelines on prostate cancer. , 2001, European urology.

[25]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[26]  T Falco,et al.  Ultrasound imaging for external-beam prostate treatment setup and dosimetric verification. , 2002, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[27]  C. Abbou,et al.  EAU guidelines on prostate cancer. , 2009, European urology.